3 Stocks Dragging The Wholesale Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 32 points (-0.2%) at 17,036 as of Thursday, Sept. 11, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,537 issues advancing vs. 1,470 declining with 140 unchanged.

The Wholesale industry currently sits up 0.4% versus the S&P 500, which is down 0.1%. A company within the industry that increased today was HD Supply Holdings ( HDS), up 1.3%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Fastenal ( FAST) is one of the companies pushing the Wholesale industry lower today. As of noon trading, Fastenal is down $0.40 (-0.9%) to $46.06 on light volume. Thus far, 316,894 shares of Fastenal exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $46.02-$46.37 after having opened the day at $46.22 as compared to the previous trading day's close of $46.47.

Fastenal Company, together with its subsidiaries, operates as a wholesaler and retailer of industrial and construction supplies in the United States, Canada, and internationally. The company offers fasteners and other industrial and construction supplies under the Fastenal name. Fastenal has a market cap of $13.7 billion and is part of the services sector. Shares are down 2.2% year-to-date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Fastenal a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates Fastenal as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Fastenal Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, AmerisourceBergen ( ABC) is down $0.97 (-1.2%) to $76.99 on average volume. Thus far, 810,440 shares of AmerisourceBergen exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $76.82-$77.72 after having opened the day at $77.72 as compared to the previous trading day's close of $77.96.

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. AmerisourceBergen has a market cap of $17.5 billion and is part of the services sector. Shares are up 10.9% year-to-date as of the close of trading on Wednesday. Currently there are 8 analysts that rate AmerisourceBergen a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates AmerisourceBergen as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and poor profit margins. Get the full AmerisourceBergen Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, McKesson ( MCK) is down $1.71 (-0.9%) to $193.82 on average volume. Thus far, 443,650 shares of McKesson exchanged hands as compared to its average daily volume of 966,500 shares. The stock has ranged in price between $193.52-$195.55 after having opened the day at $195.15 as compared to the previous trading day's close of $195.53.

McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. McKesson has a market cap of $45.5 billion and is part of the services sector. Shares are up 21.1% year-to-date as of the close of trading on Wednesday. Currently there are 11 analysts that rate McKesson a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates McKesson as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full McKesson Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the wholesale industry could consider iShares Dow Jones US Cons Goods ( IYK) while those bearish on the wholesale industry could consider ProShares Ultra Sht Consumer Goods ( SZK).

null

More from Markets

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge

Starbucks Slides After 'Unacceptable' Performance Leads to U.S. Store Closures

Starbucks Slides After 'Unacceptable' Performance Leads to U.S. Store Closures

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'